MedTrace Logo

Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)

NCT00940693 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-12-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether duloxetine is an effective treatment of attention deficit disorder in adults.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

duloxetine

60 mg capsule once per day for 6 weeks

DRUG

placebo

one capsule of placebo taken one a day for 6 weeks

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER

  • Université de Montréal

    lead OTHER

Principal Investigators

  • Valérie Tourjman, MD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940693 on ClinicalTrials.gov